SG10201403703XA - Methods of producing humanized non-human mammals - Google Patents
Methods of producing humanized non-human mammalsInfo
- Publication number
- SG10201403703XA SG10201403703XA SG10201403703XA SG10201403703XA SG10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA SG 10201403703X A SG10201403703X A SG 10201403703XA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- human mammals
- producing humanized
- humanized non
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0381—Animal model for diseases of the hematopoietic system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22143809P | 2009-06-29 | 2009-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201403703XA true SG10201403703XA (en) | 2014-10-30 |
Family
ID=43411395
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011084647A SG176118A1 (en) | 2009-06-29 | 2010-06-28 | Methods of producing humanized non-human mammals |
SG10201403703XA SG10201403703XA (en) | 2009-06-29 | 2010-06-28 | Methods of producing humanized non-human mammals |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011084647A SG176118A1 (en) | 2009-06-29 | 2010-06-28 | Methods of producing humanized non-human mammals |
Country Status (6)
Country | Link |
---|---|
US (1) | US20120157667A1 (en) |
EP (1) | EP2449094A4 (en) |
JP (1) | JP2012531896A (en) |
CN (1) | CN102725400A (en) |
SG (2) | SG176118A1 (en) |
WO (1) | WO2011002727A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3417701T (en) | 2009-10-06 | 2022-03-16 | Univ Yale | Genetically modified mice and engraftment |
FI3375284T3 (en) | 2011-02-15 | 2023-06-15 | Regeneron Pharma | Humanized m-csf mice and uses thereof |
SG11201402112RA (en) * | 2011-12-06 | 2014-09-26 | Massachusetts Inst Technology | Use of humanized mice to determine toxicity |
CN103387955B (en) * | 2012-05-10 | 2015-04-29 | 上海南方模式生物科技发展有限公司 | Making method and use of non-human mammal B lymphocyte defect animal model |
WO2014039733A1 (en) * | 2012-09-05 | 2014-03-13 | University Of Southern California | Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins |
KR102340059B1 (en) * | 2012-09-07 | 2021-12-17 | 예일 유니버시티 | Genetically modified non-human animals and methods of use thereof |
ES2748662T3 (en) | 2012-11-05 | 2020-03-17 | Institute For Res In Biomedicine Irb | Genetically modified immunodeficient rodents and methods of using them |
WO2014121840A1 (en) * | 2013-02-07 | 2014-08-14 | Medizinische Hochschule Hannover | Induced dendritic cells and uses thereof |
SG11201509981WA (en) * | 2013-06-05 | 2016-01-28 | Agency Science Tech & Res | A humanized mouse model for study of bona fide hepatitis virus infection and use thereof |
NO2785538T3 (en) * | 2014-05-07 | 2018-08-04 | ||
FI3841877T3 (en) * | 2014-05-19 | 2023-12-01 | Regeneron Pharma | Genetically modified mice expressing human epo |
CN113424798B (en) | 2015-04-13 | 2023-01-13 | 再生元制药公司 | Humanized SIRP alpha-IL 15 knock-in mice and methods of use thereof |
JP6654001B2 (en) * | 2015-05-27 | 2020-02-26 | 公益財団法人実験動物中央研究所 | Human IL-15 secreting immunodeficient mouse |
JP2019508014A (en) * | 2015-11-30 | 2019-03-28 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Generation of human macrophages in an immunodeficient non-human host |
WO2019098362A1 (en) * | 2017-11-17 | 2019-05-23 | 国立大学法人筑波大学 | Non-human animal and method for producing same |
CN111172190B (en) * | 2018-12-25 | 2021-07-30 | 百奥赛图江苏基因生物技术有限公司 | Construction method and application of humanized cell factor CSF2 gene modified non-human animal |
CN111304248B (en) * | 2018-12-25 | 2021-08-24 | 百奥赛图江苏基因生物技术有限公司 | Construction method and application of humanized cytokine IL15 gene modified non-human animal |
EP3900529B1 (en) | 2019-01-28 | 2024-01-10 | Central Institute For Experimental Animals | Rodent having a human il-34 gene and human cd34-positive hematopoietic stem cells, and use therefor |
WO2020168029A1 (en) * | 2019-02-13 | 2020-08-20 | The Jackson Laboratory | Transgenic mouse models supporting innate immune function |
CN113614238A (en) * | 2019-03-28 | 2021-11-05 | 公益财团法人实验动物中央研究所 | Immunodeficient mice |
CN111485001A (en) * | 2020-04-14 | 2020-08-04 | 澎立生物医药技术(上海)有限公司 | Construction method of humanized immune system mouse with NK (Natural killer) cell and ADCC (advanced Charge coupled device) capabilities |
EP4179080A1 (en) * | 2020-07-08 | 2023-05-17 | The Jackson Laboratory | Transgenic mouse models supporting human innate immune function |
CN112042597B (en) * | 2020-07-22 | 2022-04-29 | 南京普恩瑞生物科技有限公司 | Construction method of double humanized tumor xenograft model |
CN114853871B (en) * | 2021-04-20 | 2024-04-05 | 百奥赛图(北京)医药科技股份有限公司 | Humanized non-human animal of CSF1 and/or CSF1R gene, construction method and application thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0322240B1 (en) * | 1987-12-23 | 1995-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric immunocompromised mammals and their use |
US5639939A (en) * | 1987-12-23 | 1997-06-17 | The Board Of Trustees For The Leland Stanford Junior University | Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue |
CA2174729A1 (en) * | 1993-12-17 | 1995-06-22 | Benjamin P. Chen | A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof |
US6015554A (en) * | 1995-06-07 | 2000-01-18 | Systemix, Inc. | Method of reconstituting human lymphoid and dendritic cells |
US6060643A (en) * | 1995-08-04 | 2000-05-09 | Emory University | Mouse model with human immune system |
US20070021364A1 (en) * | 1995-12-13 | 2007-01-25 | Hans Herweijer | Methods for genetic immunization |
WO1999061589A2 (en) * | 1998-05-28 | 1999-12-02 | St. Jude Children's Research Hospital | Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof |
EP1084227A4 (en) * | 1998-05-29 | 2002-06-12 | Univ Jefferson | Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
JP2006501177A (en) * | 2002-06-24 | 2006-01-12 | ジェンザイム・コーポレイション | Methods for delivering gene therapy drugs |
GB0406728D0 (en) * | 2004-03-25 | 2004-04-28 | Hydrodynamic Gene Delivery Ltd | Gene therapy |
KR20070099550A (en) * | 2004-10-25 | 2007-10-09 | 셀러랜트 세라퓨틱스 인코퍼레이티드 | Methods of expanding myeloid cell populations and uses thereof |
WO2007120811A2 (en) * | 2006-04-14 | 2007-10-25 | Advanced Cell Technology, Inc. | Hemangio-colony forming cells |
KR20090130236A (en) * | 2007-03-13 | 2009-12-21 | 내셔날 쥬이쉬 헬스 | Methods for generation of antibodies |
US20090215875A1 (en) * | 2008-02-25 | 2009-08-27 | Deneault Eric | Methods and kits for expanding hematopoietic stem cells |
WO2010115115A1 (en) * | 2009-04-03 | 2010-10-07 | Inserm ( Institut National De La Sante Et De La Recherche) | Dendritic cell-boosted humanized immune system mice |
EP2448967B1 (en) * | 2009-06-29 | 2015-04-15 | Ilya B. Leskov | Non-human mammal model of human hematopoietic cancer |
PT3417701T (en) * | 2009-10-06 | 2022-03-16 | Univ Yale | Genetically modified mice and engraftment |
-
2010
- 2010-06-28 SG SG2011084647A patent/SG176118A1/en unknown
- 2010-06-28 WO PCT/US2010/040260 patent/WO2011002727A1/en active Application Filing
- 2010-06-28 US US13/381,313 patent/US20120157667A1/en not_active Abandoned
- 2010-06-28 JP JP2012517837A patent/JP2012531896A/en active Pending
- 2010-06-28 CN CN2010800388479A patent/CN102725400A/en active Pending
- 2010-06-28 SG SG10201403703XA patent/SG10201403703XA/en unknown
- 2010-06-28 EP EP10794611.3A patent/EP2449094A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2449094A4 (en) | 2013-07-10 |
EP2449094A1 (en) | 2012-05-09 |
CN102725400A (en) | 2012-10-10 |
WO2011002727A9 (en) | 2011-02-24 |
JP2012531896A (en) | 2012-12-13 |
SG176118A1 (en) | 2011-12-29 |
WO2011002727A1 (en) | 2011-01-06 |
US20120157667A1 (en) | 2012-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201403703XA (en) | Methods of producing humanized non-human mammals | |
HK1154463A1 (en) | Antibody producing non-human mammals | |
EP2346994A4 (en) | Non-human mammals for the production of chimeric antibodies | |
IL229118A0 (en) | Method for producing phenylacetamide compound | |
IL248217B (en) | Method of producing ingenol-3-angelate | |
EP2646879A4 (en) | Method of producing toner | |
IL217919A0 (en) | Humanized anti-cdcp1 antibodies | |
EP2528864A4 (en) | Method of producing cyclohexasilane compounds | |
EP2418227A4 (en) | Method for producing stabilized fluoropolymer | |
HUE052073T2 (en) | Method for producing phosgene | |
GB2469158B (en) | Base-assisted formation of tin-sucrose adducts | |
EP2474560A4 (en) | Method for producing 11-sugar sialyloligosaccharide-peptide | |
PL2432877T3 (en) | Method for producing (+) -zizaene | |
EP2612748A4 (en) | Method for producing molded gasket | |
IL214287A0 (en) | Method for producing 2-aminobiphenylene | |
GB2465047B (en) | Prediction of signals | |
HRP20130605T1 (en) | Method for producing die-cast parts | |
PT2760619T (en) | Structure producing method | |
EP2694461A4 (en) | Manufacture of methanol | |
EP2494028A4 (en) | Methods of increasing yields of pleuromutilins | |
EP2420492A4 (en) | Method for producing 2-halogeno-6-substituted-4-trifluoromethylpyridine | |
PL386122A1 (en) | Method of producing styrofoam with high thermoisolation | |
GB0900522D0 (en) | Method of producing archtectural moulding | |
PL387300A1 (en) | Method of manufacturing oligocarbonatediols from dimethyl carbonate | |
GB0909872D0 (en) | Method of producing presentations |